PHAT
Phathom Pharmaceuticals, Inc. Common StockData: 2026-10-23
Quick Stats
Oct 23, 202648.4
AI Score
HOLD2.04
Volume Ratio
Oct 29, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
PHAT Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
PHAT Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
PHAT Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Daily Out of Money Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Daily In the Money Options - Sort by Max open Interest (near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Most Active Options by Volume(near term)
23rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PHAT Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PHAT Stock Summary
Last updated Oct 23, 2026
PHAT is currently trading at $5.5, positioned below its 200-day moving average of $10.67, suggesting bearish momentum. The stock has a 52-week range of $5.015 to $18.31.
Technical Analysis: The 50-day moving average stands at $7.95, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.115, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.047, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PHAT at 48.4/100 with a HOLD recommendation.
PHAT (Phathom Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Oct 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 29.115 |
| CMF (20) | -0.047 |
| ROC (10) | -21.517 |
| ADX (14) | 21.529 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.352 |
| AROONOSC (14) | -50.0 |
| WILLAMS %R (14) | -92.906 |
| MFI (14) | 43.251 |
PHAT Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Oct 19 | Thrusting Line | Bearish | 50.0% | +3.0 pts | 9556 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Phathom Pharmaceuticals, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.
PHAT Moving Averages Analysis
PHAT (Phathom Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Oct 23, 2026
| Days | MA |
|---|---|
| 10 | 6.95 |
| 20 | 7.01 |
| 30 | 7.22 |
| 50 | 7.95 |
| 100 | 9.2 |
| 200 | 10.67 |
PHAT Fundamental Analysis
| P/E (Forward) | 6.5963 |
| P/E (Trailing) | -- |
| Market Cap ($) | 568.7 million |
| Earnings/Share ($) | -1.26 |
| Net Profit Margin (%) | -0.4134 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.0438 |
| EPS Estimate Next Year ($) | 0.9638 |
| WallStreet Target Price ($) | 19.64 |
| Most Recent Quarter |
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.